Padraig Donlon, PhD, currently serves as an AD Associate at Quell Therapeutics since February 2022. Prior experience includes a position as a Postdoctoral Researcher at CÚRAM, SFI Research Centre for Medical Devices, where responsibilities involved the design, development, and validation of immunohistochemical and flow cytometric assays, alongside extensive experience in flow cytometer maintenance. Padraig completed a PhD in Pharmacology at the University of Galway from September 2017 to September 2021, with research focusing on hyperthermia as a treatment for adrenal hyper steroidogenic tumors. Additional experience includes a role as a Laboratory Assistant at the Irish Blood Transfusion Service, where duties encompassed blood sample archiving and laboratory maintenance. Educational qualifications consist of a Master of Science in Regenerative Medicine and a Bachelor of Science in Genetics and Cell Biology, both from institutions in Ireland.